# OptimizeRx Corp: Form 8-K, filed Apr 18, 2025

- Company: [OptimizeRx Corp](/companies/oprx.md) (CIK 1448431)
- Form: 8-K
- Filed: 2025-04-18
- Accepted by EDGAR: Apr 18, 2025, 20:30 ET
- Period: 2025-04-18
- Accession: 0001213900-25-033402
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1448431/000121390025033402/ea0238866-8k_optimize.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1448431/000121390025033402/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1448431/000121390025033402/ea0238866-8k_optimize.htm

Filed Apr 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-033402. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.